ArticleAmerican journal of hematology2025

Outcomes of Post-Transplant Rh-GCSF and Decitabine Maintenance Therapy in Patients With High-Risk Myeloid Neoplasm.

Mathias Palmer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.